369.20
0.22%
Axis Direct
Biocon Ltd is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immune suppressants and anti-diabetic drugs.
Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.
More from Biocon Ltd.
All earning calls
Investor presentations from Biocon Ltd.
All investor presentations